| [1] |
Slots J. Periodontitis: facts, fallacies and the future[J]. Periodontol 2000, 2017, 75(1): 7-23.
|
| [2] |
Hajishengallis G. Interconnection of periodontal disease and comorbidities: evidence, mechanisms, and implications[J]. Periodontol 2000, 2022, 89(1): 9-18.
|
| [3] |
Villar A, Paladini S, Cossatis J. Periodontal disease and Alzheimer′s: insights from a systematic literature network analysis[J]. J Prev Alzheimers Dis, 2024, 11(4): 1148-1165.
|
| [4] |
Scheltens P, de Strooper B, Kivipelto M, et al. Alzheimer′s disease[J]. Lancet, 2021, 397(10284): 1577-1590.
|
| [5] |
Tolosa E, Garrido A, Scholz S W, et al. Challenges in the diagnosis of Parkinson′s disease[J]. Lancet Neurol, 2021, 20(5): 385-397.
|
| [6] |
Liccardo D, Marzano F, Carraturo F, et al. Potential bidirectional relationship between periodontitis and Alzheimer′s disease[J]. Front Physiol, 2020, 11: 683.
|
| [7] |
Kanimozhi, Aishwarya K, Yadav S, et al. Exploring the link between periodontal disease and systemic conditions: implications for Alzheimer′s, Parkinson′s, and rheumatoid arthritis[J]. J Pharm Bioallied Sci, 2024, 16(Suppl 4): S3775-S3777.
|
| [8] |
Li R H, Wang J N, Xiong W, et al. The oral-brain axis: can periodontal pathogens trigger the onset and progression of Alzheimer′s disease?[J]. Front Microbiol, 2024, 15: 1358179.
|
| [9] |
de Diego-Otero Y, El Bekay R, García-Guirado F, et al. Apocynin, a selective NADPH oxidase (Nox2) inhibitor, ameliorates behavioural and learning deficits in the fragile X syndrome mouse model[J]. Biomedicines, 2024, 12(12): 2887.
|
| [10] |
Hou L Y, Sun F Q, Huang R X, et al. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson′s disease model[J]. Redox Biol, 2019, 22: 101134.
|
| [11] |
Joseph E, Villalobos-Acosta D M Á, Torres-Ramos M A, et al. Neuroprotective effects of apocynin and galantamine during the chronic administration of scopolamine in an Alzheimer′s disease model[J]. J Mol Neurosci, 2020, 70(2): 180-193.
|
| [12] |
Jungbauer G, Stähli A, Zhu X L, et al. Periodontal microorganisms and Alzheimer disease: a causative relationship?[J]. Periodontol 2000, 2022, 89(1): 59-82.
|
| [13] |
Cichońska D, Mazuś M, Kusiak A. Recent aspects of periodontitis and Alzheimer′s disease: a narrative review[J]. Int J Mol Sci, 2024, 25(5): 2612.
|
| [14] |
Lei S, Li J, Yu J J, et al. Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway[J]. Int J Oral Sci, 2023, 15(1): 3.
|
| [15] |
Qian X S, Lin X X, Hu W Q, et al. Intestinal homeostasis disrupted by periodontitis exacerbates Alzheimer′s Disease in APP/PS1 mice[J]. J Neuroinflammation, 2024, 21(1): 263.
|
| [16] |
Shen H, Jiang Y T, Qiu C, et al. Abnormal amyloid precursor protein processing in periodontal tissue in a murine model of periodontitis induced by Porphyromonas gingivalis[J]. J Periodontal Res, 2024, 59(2): 395-407.
|
| [17] |
Jiang M Z, Zhang X W, Yan X, et al. GSK3β is involved in promoting Alzheimer′s disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice[J]. Brain Behav Immun, 2021, 98: 1-12.
|
| [18] |
Zhang X, Zhang X, Qiu C, et al. The imbalance of Th17/Treg via STAT3 activation modulates cognitive impairment in P. gingivalis LPS-induced periodontitis mice[J]. J Leukoc Biol, 2021, 110(3): 511-524.
|
| [19] |
Qiu C, Yuan Z, He Z Y, et al. Lipopolysaccharide preparation derived from Porphyromonas gingivalis induces a weaker immuno-inflammatory response in BV-2 microglial cells than Escherichia coli by differentially activating TLR2/4-mediated NF-κB/STAT3 signaling pathways[J]. Front Cell Infect Microbiol, 2021, 11: 606986.
|
| [20] |
Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities[J]. Nat Rev Immunol, 2021, 21(7): 426-440.
|
| [21] |
Huang X W, Hussain B, Chang J L. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms[J]. CNS Neurosci Ther, 2021, 27(1): 36-47.
|
| [22] |
Sweeney M D, Zhao Z, Montagne A, et al. Blood-brain barrier: from physiology to disease and back[J]. Physiol Rev, 2019, 99(1): 21-78.
|
| [23] |
Zlokovic B V. The blood-brain barrier in health and chronic neurodegenerative disorders[J]. Neuron, 2008, 57(2): 178-201.
|